Summit Financial Group Inc. Lowers Position in Abbott Laboratories (NYSE:ABT)
Summit Financial Group Inc. cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 10.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,366 shares of the healthcare product maker’s stock after selling 640 shares during the quarter. Summit Financial […]